reviews on glp 1 for weight loss Poll: in 8 Adults Say They Are Currently Taking a GLP-1 Drug Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Understanding GLP-1 and Its Role
Description
reducing reliance on costly imports." Key findings: With 98 GLP-1 drugs in trials, patent expiry in 2026 enabling biosimilars, and a projected $150B market by 2035, China could challenge Western dominancedespite regulatory hurdles and US tariffs
SURMOUNT-1: Tirzepatide Once Weekly for Obesity (NEJM, 2022) 2.Fras et al
Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph
According to NICE guidance (NG28), the continuation of GLP-1 receptor agonist therapy in type 2 diabetes should be assessed after six months, with treatment continued only if there is a reduction in HbA1c of at least 11 mmol/mol (1%) and, where applicable, a weight loss of at least 3% of initial body weight
Skip if: you have 50+ pounds to lose, or you live in AL, AR, IA, LA, or MS
